Investors

We thank our investors for their support as we advance our pipeline of immune-modulation therapies


Themis is supported by a consortium of experienced life science investors including Global Health Investment Fund, aws Gruenderfonds, Omnes Capital, Ventech and Wellington Partners Life Sciences